Deputy Manager- Engineering

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to customers across different geographies. The business is structured into two main segments: Specialty Pharmaceuticals and Generics & APIs. Specialty Pharmaceuticals includes Radiopharmaceuticals, Contract Manufacturing of Sterile Injectable, Non-sterile & Allergy Therapy Products. Generics & APIs include Solid Dosage Formulations & Active Pharmaceutical Ingredients. Jubilant Generics (JGL) is a wholly-owned subsidiary of Jubilant Pharma with Research & Development units in Noida and Mysore, India. The company operates manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, focusing on APIs and Dosage manufacturing. The Mysore manufacturing site, spread over 69 acres, is USFDA approved and manufactures APIs targeting Lifestyle-driven Therapeutic Areas like CVS and CNS. It is a market leader in four APIs and among the top three players for another three APIs. The Roorkee facility is state-of-the-art and approved by USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA, focusing on a B2B model for EU, Canada, and emerging markets. Both manufacturing units are backed by around 500 research and development professionals based at Noida and Mysore. The R&D team works on developing new products in API, Solid Dosage Formulations, Sterile Injectable, Semi-Solids Ointments, Creams, and Liquids. In-house BA/BE studies are conducted at an 80-bed facility with global regulatory accreditations. JGL's Regulatory Affairs & IPR professionals manage a unique portfolio of patents and product filings in regulatory and non-regulatory markets. Jubilant Pharma's revenue has been on a consistent growth trajectory, with INR 53,240 Million in the Financial Year 2018-19 compared to INR 39,950 Million in 2017-18. For more information about the organization, please visit www.jubilantpharma.com.,